Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines.
Allergy
2021
76
1
59-70
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines.
Allergy
2021
76
1
45-58
CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis.
J Invest Dermatol
2021
141
3
681-685.e6
Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study.
J Eur Acad Dermatol Venereol
2021
35
1
123-134
Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins.
Allergy
2021
76
4
1158-1172
Multiple pustular lesions in a patient with ulcerative colitis - successfully treated with TNF-alpha-inhibitor.
J Dtsch Dermatol Ges
2021
19
5
782-784
Transferability of suggested molecular classifiers for psoriasis and eczema to the Chinese population.
J Eur Acad Dermatol Venereol
2021
35
3
e189-e192